Articles

Developing Key Messages

May 8, 2017

By Alissa Gould, public relations manager, Boiron USA May 1, 2017 Last month (April 2017), I shared an article on being prepared and asking the right questions for media interviews or other situations. This article builds on reviewing communications basics by discussing message development. Whether you are meeting a retailer or health care professional, talking…

Be Prepared: Media Basics for the Non-PR Expert

April 5, 2017

By Alissa Gould, public relations manager, Boiron USA April 1, 2017 As more people discover the benefits of homeopathic medicines, our industry may become a larger target for skeptics or media struggling to attract an audience through sensationalized stories. This, unfortunately, is a growing pain of success. Whether you work in operations and manufacturing, medical…

Outlook 2017

March 2, 2017

By Mark Land, AAHP President March 1, 2017 2017 is shaping up to be a year in motion—both for our industry and our country. With a new Administration and Congress, continued effects of 2016 statements and warnings from federal agencies, and even personnel transitions within these agencies, 2017 will be full of changes, for better…

Manufacturers of Homeopathic Medicines Review FDA Test Results and New Application of Technology

February 15, 2017

MILWAUKIE, Ore., Feb. 14, 2017 — The U.S. Food and Drug Administration (FDA) announced on Jan. 27 that its laboratory analysis found inconsistent levels of some specific constituents in certain homeopathic teething tablets. While the industry fully supports and shares the agency’s efforts to safeguard public health, the American Association of Homeopathic Pharmacists (AAHP) cautions…

The Story of Homeopathy Told in Upcoming Feature Documentary

September 2, 2016

The homeopathic community has no shortage of positive stories to tell—from the ways our drugs have improved the health of countless individuals, to the ways we support and empower the communities in which we work. The more we can get out the word about the remarkable benefits of homeopathy, the better! The upcoming feature-length documentary…

Is Your Arnica Contaminated?

September 1, 2016

The American Botanical Council (ABC) has published their latest Adulteration Bulletin and it addresses our industry’s most widely used herb: Arnica. Adulteration of this source material can be devastating to homeopathic manufacturers who heavily rely on it for topical products. ABC’s Bulletin notes that some raw materials labeled as “Arnica montana” actually contain Mexican arnica,…

Only the Best Products Should Reach the Market

August 30, 2016

By Mark Land, AAHP President Many of today’s homeopathic products originated because of the contributions of our predecessors. These medicines were developed based on the medical expertise of ancestor homeopaths, often motivated by a perceived need in the market or a passionate pursuit of a specific therapeutic area. Today the development of health care products…

Adulterants in Your Botanical Source Materials – How Do You Know?

June 27, 2016

By Eric L. Foxman, R.Ph Many commercially available botanical products have been adulterated prior to their introduction to the market. This is a problem that has only recently come under a glaring spotlight because of the actions of the New York Attorney General’s office. While the A.G.’s testing and conclusion proved to be of flawed…

FDA Guidance for Industry – Request for Quality Metrics

June 2, 2016

By Mark Land, AAHP President FDA published its draft guidance, Request for Quality Metrics; Guidance for Industry1. Advancing the background on the initiative in general, this draft reveals 10 mandatory metrics emanating from manufacturing and laboratory systems. It also requests comments on three optional metrics: 1) senior management engagement, 2) the corrective and preventative actions…

Homeopathic Drug Labels: Rx or OTC?

June 1, 2016

By J.P. Borneman, Ph.D. and Alvin J. Lorman Homeopathic drugs, we proudly tell folks, really are drugs: the Federal Food, Drug, and Cosmetic Act has recognized them as such since its passage in 1938. Being characterized as a drug has many implications: our products are subject to current Good Manufacturing Practices, they must be produced…

Leave a Comment

You must be logged in to post a comment.